Currently, there are 154.38M common shares owned by the public and among those 146.28M shares have been available to trade.
The company’s stock has a 5-day price change of -3.49% and 5.64% over the past three months. CNX shares are trading 27.30% year to date (YTD), with the 12-month market performance up to 37.92% higher. It has a 12-month low price of $18.17 and touched a high of $26.60 over the same period. CNX has an average intraday trading volume of 2.55 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.10%, 1.86%, and 13.52% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of CNX Resources Corp (NYSE: CNX) shares accounts for 104.04% of the company’s 154.38M shares outstanding.
It has a market capitalization of $3.90B and a beta (3y monthly) value of 1.38. The stock’s trailing 12-month PE ratio is 4.63, while the earnings-per-share (ttm) stands at $5.50. The company has a PEG of 0.11 and a Quick Ratio of 0.51 with the debt-to-equity ratio at 0.56. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.07% over the week and 2.00% over the month.
Earnings per share for the fiscal year are expected to decrease by -29.61%, and 44.05% over the next financial year. EPS should grow at an annualized rate of 41.60% over the next five years, compared to 19.28% over the past 5-year period.
Looking at the support for the CNX, a number of firms have released research notes about the stock. BofA Securities stated their Neutral rating for the stock in a research note on January 05, 2024, with the firm’s price target at $23. Stephens on their part issued Equal-Weight rating on April 25, 2023.
